Replication analysis of variants associated with multiple sclerosis risk. 2020

Mohammad Dashti, and Khadijah Ateyah, and Raed Alroughani, and Rabeah Al-Temaimi
Genetics and Bioinformatics department, Dasman Diabetes Institute, Sharq, Kuwait City, Kuwait.

Multiple Sclerosis (MS) is a complex chronic neurodegenerative disorder resulting from an autoimmune reaction against myelin. So far, many genetic variants have been reported to associate with MS risk however their association is inconsistent across different populations. Here we investigated the association of the most consistently reported genetic MS risk variants in the Kuwaiti MS population in a case-control study designs. Of the 94 reported MS risk variants four variants showed MS risk association in Arabs exome analysis (EVI5 rs11808092 p = 0.0002; TNFRSF1A rs1800693 p = 0.00003; MTHFR rs1801131 p = 0.038; and CD58 rs1414273 p = 0.00007). Replication analysis in Kuwaiti MS cases and healthy controls confirmed EVI5 rs11808092A (OR: 1.6, 95%CI: 1.19-2.16, p = 0.002) and MTHFR rs1801131G (OR: 1.79, 95%CI: 1.3-2.36, p = 0.001) as MS risk genetic factors, while TNFRSF1A rs1800693C had a marginal MS risk association (OR: 1.36, 95%CI: 1.04-1.78, p = 0.025) in the Kuwaiti population. CD58 rs1414273 did not sustain risk association (p = 0.37). In conclusion, EVI5 rs11808092A, TNFRSF1A rs1800693C and MTHFR rs1801131G are MS risk factors in the Kuwaiti population. Further investigations into their roles in MS pathogenesis and progression are merited.

UI MeSH Term Description Entries
D007730 Kuwait A country located in the MIDDLE EAST, bordering the Persian Gulf, between IRAQ and SAUDI ARABIA. The capital is Kuwait City.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D005260 Female Females
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000483 Alleles Variant forms of the same gene, occupying the same locus on homologous CHROMOSOMES, and governing the variants in production of the same gene product. Allelomorphs,Allele,Allelomorph
D012306 Risk The probability that an event will occur. It encompasses a variety of measures of the probability of a generally unfavorable outcome. Relative Risk,Relative Risks,Risk, Relative,Risks,Risks, Relative

Related Publications

Mohammad Dashti, and Khadijah Ateyah, and Raed Alroughani, and Rabeah Al-Temaimi
July 2008, PloS one,
Mohammad Dashti, and Khadijah Ateyah, and Raed Alroughani, and Rabeah Al-Temaimi
June 2011, Acta neurologica Scandinavica,
Mohammad Dashti, and Khadijah Ateyah, and Raed Alroughani, and Rabeah Al-Temaimi
July 2013, Neurology,
Mohammad Dashti, and Khadijah Ateyah, and Raed Alroughani, and Rabeah Al-Temaimi
November 2015, Multiple sclerosis (Houndmills, Basingstoke, England),
Mohammad Dashti, and Khadijah Ateyah, and Raed Alroughani, and Rabeah Al-Temaimi
April 2000, Acta neurologica Scandinavica,
Mohammad Dashti, and Khadijah Ateyah, and Raed Alroughani, and Rabeah Al-Temaimi
July 2019, Immunological investigations,
Mohammad Dashti, and Khadijah Ateyah, and Raed Alroughani, and Rabeah Al-Temaimi
May 2019, Neuroscience letters,
Mohammad Dashti, and Khadijah Ateyah, and Raed Alroughani, and Rabeah Al-Temaimi
March 2015, Neurology,
Mohammad Dashti, and Khadijah Ateyah, and Raed Alroughani, and Rabeah Al-Temaimi
August 2013, Multiple sclerosis (Houndmills, Basingstoke, England),
Mohammad Dashti, and Khadijah Ateyah, and Raed Alroughani, and Rabeah Al-Temaimi
January 2015, Immunogenetics,
Copied contents to your clipboard!